PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,676,000 | -67.3% | 700,000 | -45.9% | 0.03% | -66.7% |
Q2 2023 | $35,704,678 | -39.3% | 1,292,711 | -49.5% | 0.08% | -40.9% |
Q1 2023 | $58,834,000 | +603.0% | 2,558,000 | +233.5% | 0.13% | +560.0% |
Q4 2022 | $8,368,461 | +13.7% | 767,045 | -12.1% | 0.02% | +11.1% |
Q3 2022 | $7,360,000 | -7.0% | 873,045 | -12.7% | 0.02% | 0.0% |
Q2 2022 | $7,910,000 | -44.3% | 1,000,045 | +66.7% | 0.02% | -33.3% |
Q1 2022 | $14,209,000 | -7.7% | 600,045 | +33.3% | 0.03% | -3.6% |
Q4 2021 | $15,392,000 | +189.5% | 450,045 | +50.0% | 0.03% | +180.0% |
Q3 2021 | $5,317,000 | -78.5% | 300,045 | -45.5% | 0.01% | -79.2% |
Q2 2021 | $24,686,000 | +58.8% | 550,045 | -8.3% | 0.05% | +50.0% |
Q1 2021 | $15,541,000 | -33.0% | 600,045 | -47.8% | 0.03% | -37.3% |
Q4 2020 | $23,185,000 | -53.0% | 1,150,045 | -54.4% | 0.05% | -58.5% |
Q3 2020 | $49,278,000 | +26.8% | 2,520,600 | +14.6% | 0.12% | +24.2% |
Q2 2020 | $38,852,000 | +1056.3% | 2,200,000 | +340.0% | 0.10% | +1137.5% |
Q2 2018 | $3,360,000 | -60.9% | 500,000 | -50.0% | 0.01% | -60.0% |
Q1 2018 | $8,590,000 | -79.9% | 1,000,000 | -51.4% | 0.02% | -79.4% |
Q4 2017 | $42,766,000 | +17.7% | 2,056,076 | 0.0% | 0.10% | +10.2% |
Q3 2017 | $36,331,000 | +56.2% | 2,056,076 | 0.0% | 0.09% | +54.4% |
Q2 2017 | $23,254,000 | +9.6% | 2,056,076 | +24.2% | 0.06% | +7.5% |
Q1 2017 | $21,214,000 | -37.0% | 1,656,076 | +8.2% | 0.05% | -42.4% |
Q4 2016 | $33,668,000 | +0.8% | 1,531,076 | -3.2% | 0.09% | 0.0% |
Q3 2016 | $33,408,000 | – | 1,581,076 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |